Megmento Pharmaceuticals Private Limited

Megmento Pharmaceuticals Private Limited - pharma in Bhubaneswar, Orissa, India. FY 2026 financials & compliance.
CIN U24299OR2021PTC035944 Incorporated 19 March 2021 ROC Cuttack HQ Bhubaneswar, Orissa, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹2.1 Cr
▲ 97.00% YoY
Net profit · FY 2024
₹10.4 Lakh
Net margin 5%
EBITDA · FY 2024
₹38.5 Lakh
EBITDA margin 18.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
29
Provident fund records
Directors on board
3
As per MCA filings

About Megmento Pharmaceuticals Private Limited

Data last updated:

Megmento Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Orissa, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 March 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24299OR2021PTC035944. Its GSTIN is 21AAOCM4348N1Z2 (Odisha).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anjali Agarwalla and Prabhat Kumar Choubey.

Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 101 Metro Emerald P.S – Laxmi Sagar, Bhubaneswar, Orissa, India – 751006.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.1 Cr, a growth of 97% compared to the previous year. For the same year it recorded a net profit of ₹10.4 Lakh (net margin 5%) and EBITDA of ₹38.5 Lakh (EBITDA margin 18.4%).

The company has about 29 employees on its provident fund (EPFO) records.

Company Details of Megmento Pharmaceuticals Private Limited
CIN U24299OR2021PTC035944
Registration Number 035944
Incorporation Date 19 March 2021
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No – 101 Metro Emerald P.S – Laxmi Sagar, Bhubaneswar, Orissa, India – 751006
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Megmento Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Megmento Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Megmento Pharmaceuticals Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Megmento Pharmaceuticals Private Limited

The main business activity of Megmento Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Megmento Pharmaceuticals Private Limited

Megmento Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anjali AgarwallaDirector19 Mar 20215 Years 6 MonthsCurrent
Prabhat Kumar ChoubeyDirector19 Mar 20215 Years 6 MonthsCurrent
Karishma SharmaAdditional Director09 Nov 20232 Years 10 MonthsCurrent

Financials of Megmento Pharmaceuticals Private Limited FY 2025 filings available

Megmento Pharmaceuticals Private Limited reported revenue of ₹2.1 Cr (up 97.00% YoY) for FY 2024.

Revenue · FY 2024
₹2.1 Cr ▲ 97.00%
Net profit · FY 2024
₹10.4 Lakh margin 5%
EBITDA · FY 2024
₹38.5 Lakh margin 18.4%

Financial Statement Summary of Megmento Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹38.5 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹10.4 Lakh••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Megmento Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin18.4%••••••••••••
Net Profit Margin5%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Megmento Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Megmento Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Megmento Pharmaceuticals Private Limited

Megmento Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Megmento Pharmaceuticals Private Limited

Megmento Pharmaceuticals Private Limited has a workforce of 29 employees as of Apr 08, 2024.

Employee count
29
Active EPFO establishments
1
Employee growth
61.11%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Megmento Pharmaceuticals Private Limited

Megmento Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
21AAOCM4348N1Z2OdishaActive17 Nov 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Megmento Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Megmento Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Megmento Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Megmento Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Megmento Pharmaceuticals Private Limited

Activity
12 Sep 2025
Megmento Pharmaceuticals Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Megmento Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Directors
09 Nov 2023
Karishma Sharma was appointed as a Additional Director on 09 Nov 2023 & has been associated with this company since 2 years 10 months.
Directors
19 Mar 2021
Anjali Agarwalla was appointed as a Director on 19 Mar 2021 & has been associated with this company since 5 years 6 months.
Directors
19 Mar 2021
Prabhat Kumar Choubey was appointed as a Director on 19 Mar 2021 & has been associated with this company since 5 years 6 months.
Activity
19 Mar 2021
Megmento Pharmaceuticals Private Limited was registered on 19 Mar 2021 with Roc Cuttack & aged 5 years 6 months as per MCA records.

Frequently Asked Questions about Megmento Pharmaceuticals Private Limited

Megmento Pharmaceuticals is an active private limited company based in Bhubaneswar, Orissa, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 March 2021 (5+ years old) and is registered under CIN U24299OR2021PTC035944.

Megmento Pharmaceuticals reported revenue of ₹2.1 Cr for FY 2024 (up 97.00% YoY).

Megmento Pharmaceuticals has 3 current directors:

Megmento Pharmaceuticals reported a net profit of ₹10.4 Lakh (net margin 5%) and EBITDA of ₹38.5 Lakh (EBITDA margin 18.4%) for FY 2024, as per its filed financial statements.

The GSTIN of Megmento Pharmaceuticals is 21AAOCM4348N1Z2, registered in Odisha.

The CIN (Corporate Identification Number) of Megmento Pharmaceuticals is U24299OR2021PTC035944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Megmento Pharmaceuticals was incorporated on 19 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Cuttack.

The registered office of Megmento Pharmaceuticals is at Plot No – 101 Metro Emerald P.S – Laxmi Sagar, Bhubaneswar, Orissa, India – 751006.

Megmento Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available